Reducing Fraud and Lowering Barriers to the Production of Drugs in Shortage by Outsourcing Facilities

Key facts

Copied from the official Grants.gov record. Last verified October 29, 2026.

Program name

Reducing Fraud and Lowering Barriers to the Production of Drugs in Shortage by Outsourcing Facilities

Issuing agency

Food and Drug Administration (Department of Health and Human Services)

Opportunity number

FOR-FD-25-023

Funding type

Grant

Funding purpose

Food and Nutrition, Agriculture, Consumer Protection

Status

Forecasted

Application deadline

Forecasted · no application dates yet

Published award range

Up to $3,000,000

Estimated total program funding

$3,000,000

Expected number of awards

2

Cost sharing or match required

No

Eligible applicants (official categories)

• Others (see Additional Information on Eligibility)

Relevant to

Businesses and NonprofitsHow we determined this: Listed as 'Others'; the agency's eligibility text mentions businesses (flagged for review). Listed as 'Others'; the agency's eligibility text mentions nonprofits (flagged for review).

Geographic restrictions

None stated in structured data (federal opportunities are often nationwide). Check the eligibility details and full announcement for any limits.

Assistance Listing (CFDA)

93.103

Official source

View on Grants.gov ↗

Application URL

www.grants.gov/search-results-detail/360095 ↗Apply through Grants.gov (Workspace) using the application package on the official listing, unless the full announcement names a different submission system.

Source identifier

Grants.gov opportunity ID 360095 · Funding opportunity number FOR-FD-25-023

Posted

July 21, 2025 · Source last updated July 21, 2025

Last verified

October 29, 2026 (against Grants.gov)

Data completeness

92% of key fields published by the sourceNot published: application dates.

Record confidence

loweligibility described only in free text (in review); forecast — dates and amounts are agency estimates.

Eligibility details (from the agency)

Higher Education Institutions Public/State Controlled Institutions of Higher Education Private Institutions of Higher Education Nonprofits Other Than Institutions of Higher Education Nonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education) Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education) For-Profit Organizations Small Businesses For-Profit Organizations (Other than Small Businesses) Local Governments State Governments County Governments City or Township Governments Special District Governments Indian/Native American Tribal Governments (Federally Recognized) Indian/Native American Tribal Governments (Other than Federally Recognized) Federal Governments Eligible Agencies of the Federal Government U.S. Territory or Possession Other Independent School Districts Public Housing Authorities/Indian Housing Authorities Native American Tribal Organizations (other than Federally recognized tribal governments) Faith-based or Community-based Organizations Regional Organizations N/A Foreign Organizations Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Description (from the official listing)

The goals of this grant are to better understand the landscape of drug shortage products, including those vulnerable to health fraud, and identify opportunities for outsourcing facilities to meet drug shortage needs to strengthen the supply chain. Funding would also support outsourcing facilities’ research and development of products that mitigate persistent drug shortages to increase supply of critical medications and stabilize the drug supply chain to prevent health fraud.

Agency contact

Patrick Johnson
patrick.johnson@fda.hhs.gov